Bionano Genomics, Inc. Finance Lease, Liability, Current
Bionano Genomics, Inc. (BNGO) had Finance Lease, Liability, Current of $243.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:FinanceLeaseLiabilityCurrent · last filed 2026-08-10
- 2026-06-30: Finance Lease, Liability, Current $243.00K.
- 2026-03-31: Finance Lease, Liability, Current $246.00K.
- 2025-12-31: Finance Lease, Liability, Current $249.00K.
- 2025-09-30: Finance Lease, Liability, Current $251.00K.
| Period end | Finance Lease, Liability, Current |
|---|---|
| 2026-06-30 | $243.00K 10-Q · filed 2026-08-10 |
| 2026-03-31 | $246.00K 10-Q · filed 2026-05-13 |
| 2025-12-31 | $249.00K 10-Q · filed 2026-08-10 |
| 2025-09-30 | $251.00K 10-Q · filed 2025-11-13 |
| 2025-06-30 | $254.00K 10-Q · filed 2025-08-14 |
| 2025-03-31 | $257.00K 10-Q · filed 2025-05-14 |
| 2024-12-31 | $260.00K 10-K · filed 2026-03-23 |
| 2024-09-30 | $263.00K 10-Q · filed 2024-11-14 |
| 2024-06-30 | $266.00K 10-Q · filed 2024-08-07 |
| 2024-03-31 | $269.00K 10-Q · filed 2024-05-08 |
| 2023-12-31 | $272.00K 10-K · filed 2025-03-31 |
| 2023-09-30 | $276.00K 10-Q · filed 2023-11-08 |
| 2023-06-30 | $279.00K 10-Q · filed 2023-08-09 |
| 2023-03-31 | $282.00K 10-Q · filed 2023-05-09 |
| 2022-12-31 | $285.00K 10-K · filed 2024-03-05 |
| 2022-09-30 | $288.00K 10-Q · filed 2022-11-03 |
| 2022-06-30 | $292.00K 10-Q · filed 2022-08-04 |
| 2022-03-31 | $296.00K 10-Q · filed 2022-05-05 |
| 2021-12-31 | $299.00K 10-K · filed 2023-03-09 |
| 2020-12-31 | $0.00 10-K · filed 2022-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |